Laryngeal Cancer Therapeutics Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, China, Japan - Size and Forecast 2023-2027

Published: Oct 2023 Pages: 162 SKU: IRTNTR70041

Laryngeal Cancer Therapeutics Market Forecast 2023-2027

The global laryngeal cancer therapeutics market size is estimated to grow by USD 575.25 million at a CAGR of 5.43% between 2022 and 2027. 

The proactive adoption of awareness initiatives and early cancer diagnosis programs is a significant driving force in the global market. These activities empower individuals to recognize the risk factors and symptoms of laryngeal cancer, leading them to seek medical assistance at an early stage of the disease. The improved outcome of treatment and increased survival rates for patients are often the result of early detection. The number of patients who will be able to access a wider range of treatments, such as surgery, radiation therapy, and developing targeted medicines, grows.

It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historic data from 2017 to 2021, besides analyzing the current market scenario.

What will be the Size of the Laryngeal Cancer Therapeutics Market During the Forecast Period?

To learn more about this report, Request Free Sample

Market Segmentation by Type, Distribution Channel, and Geography

Application Analysis 

Biologics 

The market share growth by the biologics segment will be significant during the forecast period. Biologics are the drugs made from living organisms or drugs that contain certain components of living organisms. Monoclonal antibodies, recombinant proteins, tissues, and genes are some of the most commonly used biologics for the treatment of various oncology indications. The use of these medicinal products is frequently very effective and has little or no undesirable effects, given the high degree of stability of biologics.

Get a glance at the market contribution of various segments View a PDF Sample

The biologics segment was valued at USD 899.04 million in 2017. The ability of biologics to stimulate the body's immune system to act against cancer cells is one of the major factors for the increasing growth of this segment. The novel mechanism of action (MoA) of such drugs is expected to extend more efficient treatment, which would lead to a wider patient base, thereby driving market growth. Designations of the biological substances are supposed to lead quickly to their approval, thus adding significant value to the market growth during the forecast period.

Distribution Channel Analysis

Offline

Offline distribution channels are crucial in the market in focus. While internet platforms have grown in popularity, traditional channels remain dominant due to the sensitive nature of healthcare items and the requirement for personal consultations. Offline distribution is mainly through hospitals and specializes in laryngeal and throat Cancer treatment centers, offering a wide range of treatment options such as surgery, radiation therapy, and chemotherapy. They're providing a one-stop for patients who want to see an oncologist and get their medical care. Offline channels are expected to remain essential in this dynamic market for offering complete care and assistance to persons facing the problem and hence drive the growth of the market in focus during the forecast period.

Online

Online distribution channels are playing an important role in the market in focus. With the increased accessibility of the internet and digital platforms, these channels have become the key source of information and procurement of cancer treatment choices. Patients, carers, and health professionals can communicate with experts via the internet platforms to access current information about treatments and advice. In addition, it is possible to obtain a prescription and treatment through online pharmacies. Telemedicine services have grown in popularity, allowing for remote consultations and monitoring, which is very useful for throat cancer patients. The adoption of the online segment is expected to increase and hence drive the growth of the market in focus during the forecast period.

Regional Analysis

For more insights about the market share of various regions View PDF Sample now!

North America is estimated to contribute 43% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. In recent years, the North American market has shown a dynamic landscape. The increased incidence rates, especially due to cigarette and alcohol consumption, fuelled market expansion. 

However, the introduction of novel medicines, such as checkpoint inhibitors paired with radiation, promises to enhance patient outcomes. Furthermore, it could improve access to care by integrating telemedicine into consultations and follow-ups. Owing to all these factors, the market in North America is expected to witness strong growth during the forecast period and is expected to retain its position as the top region.

Buy Now Full Report and Discover More

Key Laryngeal Cancer Therapeutics Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

Amgen Inc. - The company offers Vectibix R as a first-line treatment in patients with recurrent and metastatic squamous cell head and neck cancer.

  • AstraZeneca Plc
  • Accord Healthcare Ltd. 
  • Athenex Inc.
  • Bayer AG
  • Bristol Myers Squibb Co.
  • Celldex Therapeutics Inc.
  • Eli Lilly and Co.
  • F. Hoffmann La Roche Ltd.
  • Fresenius SE and Co
  • KGaA
  • Hangzhou Adlai Nortye Biopharma Co. Ltd.
  • Hanmi Pharm Co. Ltd.
  • Hikma Pharmaceuticals Plc
  • Merck and Co. Inc.
  • Pfizer Inc., Regeneron Pharmaceuticals Inc.
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Market Dynamics

There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. 

Key Drivers

The increasing number of reimbursement programs is driving growth in the market. The Global market has been favorably influenced by an expanding number of reimbursement schemes. Governments all across the world are recognising the necessity of providing financial aid to cancer patients, particularly those with this problem.

However, patient access to cutting-edge treatments has been significantly improved with very little effort. These reimbursement programs not only relieve financial pressures on patients but also motivate pharmaceutical companies to spend on R&D, fostering innovation in the therapies and throat cancer industry. Such factors are expected to drive the growth of the market focus during the forecast period.

Significant Trends

The increasing prevalence of precision medicine is a key trend in the market. Tailoring treatments based on tumor genetic and molecular characteristics is a market-changing trend. The strategy of precision medicine allows a high degree of personalized and effective treatment. Clinicians can prescribe medicines that are more likely to target cancer cells with precision by analyzing the specific genetic abnormalities or biomarkers present in a patient's tumor. 

Advances in genomic sequencing technology, which provide thorough tumor profiling, are supporting this trend. It provides oncologists with the capacity to make data-driven treatment decisions that may lead to better results while reducing unnecessary treatments. Thus, the increasing prevalence of precision medicine is expected to contribute to the growth of the market in focus during the forecast period.

Major Challenges

The preference for alternative therapies is a major challenge in the market. Alternative therapies such as surgery for the removal of tumors and radiation therapy have dominated the treatment landscape for a long time. The popularity of surgery as a cancer treatment is increasing due to its high efficacy in early and late stages, especially when used with radiation therapy.

Moreover, the advances in surgical methods are helping in overcoming the challenges of side effects of the surgery, which is contributing to the increasing demand for surgery. Laser surgery performed through the mouth is a major surgical advancement that minimizes skin invasion during treatment. The increasing advances in these treatment methods are expected to pose a major challenge to the growth of the global market during the forecast period.

Buy Now Full Report and Discover More

Key Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Market Customer Landscape

Segment Overview

The market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. 

  • Type Outlook (USD Million, 2017 - 2027)
    • Biologics
    • Small molecules
  • Distribution Channel Outlook (USD Million, 2017 - 2027)
    • Offline
    • Online
  • Region Outlook (USD Million, 2017 - 2027)
    • North America
      • The U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • ROW
      • Argentina
      • Australia
      • Rest of the World 

Market Analyst Overview

The Market is influenced by various factors, including the stage of the cancer, its location within the larynx, and the overall health of the patient. Treatment approaches are tailored to individual cases, considering the patient's preferences and the availability of related products. Management often involves a combination of medical devices, surgical equipment, and diagnostic tools.

Supportive care services are crucial, especially given the incidence of laryngeal cancer and the impact of disruptions like the pandemic on healthcare systems. Delays or changes in treatment plans, including elective surgeries and non-urgent procedures, have underscored the importance of personalized medicine and genomic testing for molecular profiling and targeted therapies.

In the North America region, advanced medical facilities and research institutions collaborate with specialized cancer centers, pharmaceutical and biotechnology companies, and academic and medical institutions. Key industry players drive research and development efforts, focusing on commercialization and collaboration opportunities. Public health campaigns emphasize the importance of early detection and diagnosis, while healthcare investments spur improvements in existing therapies and regulatory compliance. Despite a declining trend in the market, ongoing efforts aim to enhance the accessibility of laryngeal cancer treatments through healthcare infrastructure enhancements and research and development initiatives.

Laryngeal Cancer Therapeutics Market Scope

Report Coverage

Details

Page number

162

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 5.43%

Market growth 2023-2027

USD 575.25 million

Market structure

Fragmented

YoY growth 2022-2023(%)

4.75

Regional analysis

North America, Europe, Asia, and the Rest of the World (ROW)

Performing market contribution

North America at 43%

Key countries

US, Germany, UK, China, and Japan

Competitive landscape

 Leading companies, Market Positioning of companies, Competitive Strategies, and Industry Risks

Key companies profiled

Accord Healthcare Ltd., Amgen Inc., AstraZeneca Plc, Athenex Inc., Bayer AG, Bristol Myers Squibb Co., Celldex Therapeutics Inc., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Fresenius SE and Co. KGaA, Hangzhou Adlai Nortye Biopharma Co. Ltd., Hanmi Pharm Co. Ltd., Hikma Pharmaceuticals Plc, Merck and Co. Inc., Pfizer Inc., Regeneron Pharmaceuticals Inc., Sanofi, Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd.

Market dynamics

Parent market analysis, Market Forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View Sample PDF at your Fingertips

What are the Key Data Covered in this Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the market growth and forecasting of the market between 2023 and 2027
  • Precise estimation of the size of the market size and its contribution to the parent market
  • Accurate predictions about upcoming market trends and analysis and changes in consumer behavior
  • Growth of the market industry across Europe, North America, APAC, South America, and Middle East and Africa
  • Thorough market growth analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive market analysis and report on the factors that will challenge the market research and growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Distribution Channel
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global laryngeal cancer therapeutics market 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on global laryngeal cancer therapeutics market 2017 - 2021 ($ million)
    • 4.2 Type Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – Type Segment 2017 - 2021 ($ million)
    • 4.3 Distribution Channel Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – Distribution Channel Segment 2017 - 2021 ($ million)
    • 4.4 Geography Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
    • 4.5 Country Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by Type

    • 6.1 Market segments
      • Exhibit 30: Chart on Type - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
    • 6.2 Comparison by Type
      • Exhibit 32: Chart on Comparison by Type
      • Exhibit 33: Data Table on Comparison by Type
    • 6.3 Biologics - Market size and forecast 2022-2027
      • Exhibit 34: Chart on Biologics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 35: Data Table on Biologics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 36: Chart on Biologics - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on Biologics - Year-over-year growth 2022-2027 (%)
    • 6.4 Small molecules - Market size and forecast 2022-2027
      • Exhibit 38: Chart on Small molecules - Market size and forecast 2022-2027 ($ million)
      • Exhibit 39: Data Table on Small molecules - Market size and forecast 2022-2027 ($ million)
      • Exhibit 40: Chart on Small molecules - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on Small molecules - Year-over-year growth 2022-2027 (%)
    • 6.5 Market opportunity by Type
      • Exhibit 42: Market opportunity by Type ($ million)
      • Exhibit 43: Data Table on Market opportunity by Type ($ million)

    7 Market Segmentation by Distribution Channel

    • 7.1 Market segments
      • Exhibit 44: Chart on Distribution Channel - Market share 2022-2027 (%)
      • Exhibit 45: Data Table on Distribution Channel - Market share 2022-2027 (%)
    • 7.2 Comparison by Distribution Channel
      • Exhibit 46: Chart on Comparison by Distribution Channel
      • Exhibit 47: Data Table on Comparison by Distribution Channel
    • 7.3 Offline - Market size and forecast 2022-2027
      • Exhibit 48: Chart on Offline - Market size and forecast 2022-2027 ($ million)
      • Exhibit 49: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
      • Exhibit 50: Chart on Offline - Year-over-year growth 2022-2027 (%)
      • Exhibit 51: Data Table on Offline - Year-over-year growth 2022-2027 (%)
    • 7.4 Online - Market size and forecast 2022-2027
      • Exhibit 52: Chart on Online - Market size and forecast 2022-2027 ($ million)
      • Exhibit 53: Data Table on Online - Market size and forecast 2022-2027 ($ million)
      • Exhibit 54: Chart on Online - Year-over-year growth 2022-2027 (%)
      • Exhibit 55: Data Table on Online - Year-over-year growth 2022-2027 (%)
    • 7.5 Market opportunity by Distribution Channel
      • Exhibit 56: Market opportunity by Distribution Channel ($ million)
      • Exhibit 57: Data Table on Market opportunity by Distribution Channel ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 59: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 60: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 61: Chart on Geographic comparison
      • Exhibit 62: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2022-2027
      • Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.4 Europe - Market size and forecast 2022-2027
      • Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.5 Asia - Market size and forecast 2022-2027
      • Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
      • Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
      • Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
      • Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • 9.7 US - Market size and forecast 2022-2027
      • Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.8 China - Market size and forecast 2022-2027
      • Exhibit 83: Chart on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 84: Data Table on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 85: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 86: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 9.9 Germany - Market size and forecast 2022-2027
      • Exhibit 87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 89: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 9.10 UK - Market size and forecast 2022-2027
      • Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%)
      • Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%)
    • 9.11 Japan - Market size and forecast 2022-2027
      • Exhibit 95: Chart on Japan - Market size and forecast 2022-2027 ($ million)
      • Exhibit 96: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
      • Exhibit 97: Chart on Japan - Year-over-year growth 2022-2027 (%)
      • Exhibit 98: Data Table on Japan - Year-over-year growth 2022-2027 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 99: Market opportunity by geography ($ million)
      • Exhibit 100: Data Tables on Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 101: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 103: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 104: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 105: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 106: Matrix on vendor position and classification
            • 12.3 Amgen Inc.
              • Exhibit 107: Amgen Inc. - Overview
              • Exhibit 108: Amgen Inc. - Product / Service
              • Exhibit 109: Amgen Inc. - Key offerings
            • 12.4 AstraZeneca Plc
              • Exhibit 110: AstraZeneca Plc - Overview
              • Exhibit 111: AstraZeneca Plc - Product / Service
              • Exhibit 112: AstraZeneca Plc - Key news
              • Exhibit 113: AstraZeneca Plc - Key offerings
            • 12.5 Bayer AG
              • Exhibit 114: Bayer AG - Overview
              • Exhibit 115: Bayer AG - Business segments
              • Exhibit 116: Bayer AG - Key news
              • Exhibit 117: Bayer AG - Key offerings
              • Exhibit 118: Bayer AG - Segment focus
            • 12.6 Bristol Myers Squibb Co.
              • Exhibit 119: Bristol Myers Squibb Co. - Overview
              • Exhibit 120: Bristol Myers Squibb Co. - Product / Service
              • Exhibit 121: Bristol Myers Squibb Co. - Key news
              • Exhibit 122: Bristol Myers Squibb Co. - Key offerings
            • 12.7 Celldex Therapeutics Inc.
              • Exhibit 123: Celldex Therapeutics Inc. - Overview
              • Exhibit 124: Celldex Therapeutics Inc. - Product / Service
              • Exhibit 125: Celldex Therapeutics Inc. - Key offerings
            • 12.8 Eli Lilly and Co.
              • Exhibit 126: Eli Lilly and Co. - Overview
              • Exhibit 127: Eli Lilly and Co. - Product / Service
              • Exhibit 128: Eli Lilly and Co. - Key news
              • Exhibit 129: Eli Lilly and Co. - Key offerings
            • 12.9 F. Hoffmann La Roche Ltd.
              • Exhibit 130: F. Hoffmann La Roche Ltd. - Overview
              • Exhibit 131: F. Hoffmann La Roche Ltd. - Business segments
              • Exhibit 132: F. Hoffmann La Roche Ltd. - Key news
              • Exhibit 133: F. Hoffmann La Roche Ltd. - Key offerings
              • Exhibit 134: F. Hoffmann La Roche Ltd. - Segment focus
            • 12.10 Hangzhou Adlai Nortye Biopharma Co. Ltd.
              • Exhibit 135: Hangzhou Adlai Nortye Biopharma Co. Ltd. - Overview
              • Exhibit 136: Hangzhou Adlai Nortye Biopharma Co. Ltd. - Product / Service
              • Exhibit 137: Hangzhou Adlai Nortye Biopharma Co. Ltd. - Key offerings
            • 12.11 Hanmi Pharm Co. Ltd.
              • Exhibit 138: Hanmi Pharm Co. Ltd. - Overview
              • Exhibit 139: Hanmi Pharm Co. Ltd. - Product / Service
              • Exhibit 140: Hanmi Pharm Co. Ltd. - Key offerings
            • 12.12 Hikma Pharmaceuticals Plc
              • Exhibit 141: Hikma Pharmaceuticals Plc - Overview
              • Exhibit 142: Hikma Pharmaceuticals Plc - Business segments
              • Exhibit 143: Hikma Pharmaceuticals Plc - Key offerings
              • Exhibit 144: Hikma Pharmaceuticals Plc - Segment focus
            • 12.13 Merck and Co. Inc.
              • Exhibit 145: Merck and Co. Inc. - Overview
              • Exhibit 146: Merck and Co. Inc. - Business segments
              • Exhibit 147: Merck and Co. Inc. - Key news
              • Exhibit 148: Merck and Co. Inc. - Key offerings
              • Exhibit 149: Merck and Co. Inc. - Segment focus
            • 12.14 Pfizer Inc.
              • Exhibit 150: Pfizer Inc. - Overview
              • Exhibit 151: Pfizer Inc. - Product / Service
              • Exhibit 152: Pfizer Inc. - Key news
              • Exhibit 153: Pfizer Inc. - Key offerings
            • 12.15 Regeneron Pharmaceuticals Inc.
              • Exhibit 154: Regeneron Pharmaceuticals Inc. - Overview
              • Exhibit 155: Regeneron Pharmaceuticals Inc. - Product / Service
              • Exhibit 156: Regeneron Pharmaceuticals Inc. - Key offerings
            • 12.16 Sanofi
              • Exhibit 157: Sanofi - Overview
              • Exhibit 158: Sanofi - Business segments
              • Exhibit 159: Sanofi - Key news
              • Exhibit 160: Sanofi - Key offerings
              • Exhibit 161: Sanofi - Segment focus
            • 12.17 Sun Pharmaceutical Industries Ltd.
              • Exhibit 162: Sun Pharmaceutical Industries Ltd. - Overview
              • Exhibit 163: Sun Pharmaceutical Industries Ltd. - Product / Service
              • Exhibit 164: Sun Pharmaceutical Industries Ltd. - Key offerings

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 165: Inclusions checklist
                • Exhibit 166: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 167: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 168: Research methodology
                • Exhibit 169: Validation techniques employed for market sizing
                • Exhibit 170: Information sources
              • 13.5 List of abbreviations
                • Exhibit 171: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              laryngeal cancer therapeutics market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis